Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Lamotrigine price, strengths & recalls

Generic of Lamictal, Subvenite

Pharmacies pay $1.45 for 30 tablets of Lamotrigine 100 mg tablet this week, and from $0.81 to $53.56 across its 17 priced strengths and forms. 41 manufacturers make it. It is in shortage (being discontinued). It has 13 recalls on record, none ongoing. Its official label last changed on June 25, 2026.

Being discontinuedGeneric
Pharmacies pay$1.45for 30 tablets of 100 mg tablet-0.8% in 4 weeks
Fair cash price
$12.17
Strengths
17
Makers
41
Updated
Nov 11

Lamotrigine price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
25 mg (24 hr) extended-release tablet$0.3615$10.84 / 30 tablets+31.4%-12.9%
50 mg (24 hr) extended-release tablet$0.5513$16.54 / 30 tablets-7.2%-20.2%
100 mg (24 hr) extended-release tablet$0.6671$20.01 / 30 tablets-0.9%-15.0%
200 mg (24 hr) extended-release tablet$0.6485$19.45 / 30 tablets+6.6%-20.7%
250 mg (24 hr) extended-release tablet$1.21$36.44 / 30 tablets-6.8%+9.3%
300 mg (24 hr) extended-release tablet$1.28$38.29 / 30 tablets+1.3%-2.4%
25 mg orally disintegrating tablet$1.28$38.39 / 30 tablets-1.5%-32.3%
50 mg orally disintegrating tablet$1.33$39.75 / 30 tablets+4.3%-21.0%
100 mg orally disintegrating tablet$1.59$47.69 / 30 tablets-2.2%-27.9%
200 mg orally disintegrating tablet$1.79$53.56 / 30 tablets+8.7%-23.9%
PackNot priced this week
Pack$9.50$9.50 / 1 kit+0.7%+2.7%
25 mg tablet$0.0270$0.81 / 30 tablets+0.8%-11.8%
100 mg tablet$0.0483$1.45 / 30 tablets-0.8%+5.4%
150 mg tablet$0.0688$2.06 / 30 tablets-1.0%+9.3%
200 mg tablet$0.0801$2.40 / 30 tablets-2.9%+1.8%
5 mg tablet for oral suspension$0.1530$4.59 / 30 tablets-8.6%-3.6%
25 mg tablet for oral suspension$0.1503$4.51 / 30 tablets+2.0%-9.9%

The lowest cost per tablet is 25 mg tablet at $0.0270. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Brand names of lamotrigine

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

In shortage6 products are short or being discontinued
No ongoing recalls13 recalls on record, latest Aug 17, 2022

Shortages

  • Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 13 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for lamotrigine? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJune 25, 2026
Version25 of 16
EffectiveMay 19, 2026
Read the label

These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS.LAMOTRIGINE Tablets, for oral useInitial U.S. Approval: 1994

This drug has a boxed warning

WARNING: SERIOUS SKIN RASHES

WARNING: SERIOUS SKIN RASHES

See full prescribing information for complete boxed warning.

Cases of life-threatening serious rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis, and/or rash-related death have been caused by lamotrigine. The rate of serious rash is greater in pediatric patients than in adults. Additional factors that may increase the risk of rash include:

coadministration with valproate.

exceeding recommended initial dose of lamotrigine.

exceeding recommended dose escalation for lamotrigine.

presence of the HLA-B*1502 allele. (5.1)

Benign rashes are also caused by lamotrigine; however, it is not possible to predict which rashes will prove to be serious or life threatening. Lamotrigine should be discontinued at the first sign of rash, unless the rash is clearly not drug related. (5.1)

Lamotrigine can cause serious rashes requiring hospitalization and discontinuation of treatment. The incidence of these rashes, which have included Stevens-Johnson syndrome, is approximately 0.3% to 0.8% in pediatric patients (aged 2 to 17 years) and 0.08% to 0.3% in adults receiving lamotrigine. One rash-related death was reported in a prospectively followed cohort of 1,983 pediatric patients (aged 2 to 16 years) with epilepsy taking lamotrigine as adjunctive therapy. In worldwide postmarketing experience, rare cases of toxic epidermal necrolysis and/or rash-related death have been reported in adult and pediatric patients, but their numbers are too few to permit a precise estimate of the rate.

In addition to age, factors that may increase the risk of occurrence or the severity of rash caused by lamotrigine include (1) coadministration of lamotrigine with valproate (includes valproic acid and divalproex sodium), (2) exceeding the recommended initial dose of lamotrigine, (3) exceeding the recommended dose escalation for lamotrigine, or (4) the presence of the HLA-B*1502 allele However, cases have occurred in the absence of these factors.

Nearly all cases of life-threatening rashes caused by lamotrigine have occurred within 2 to 8 weeks of treatment initiation. However, isolated cases have occurred after prolonged treatment (e.g., 6 months). Accordingly, duration of therapy cannot be relied upon as means to predict the potential risk heralded by the first appearance of a rash.

Although benign rashes are also caused by lamotrigine, it is not possible to predict reliably which rashes will prove to be serious or life threatening. Accordingly, lamotrigine should ordinarily be discontinued at the first sign of rash, unless the rash is clearly not drug related. Discontinuation of treatment may not prevent a rash from becoming life threatening or permanently disabling or disfiguring [see Warnings and Precautions (5.1)].

Recent major changes (as listed on the label)

Boxed Warning

| 10/2025

|

Dosage and Administration (2.1, 2.2, 2.4)

| 4/2025

|

Warnings and Precautions,

Serious Skin Rashes

| 10/2025

|

Concomitant Use with Estrogen-Containing Products, Including Oral

Contraceptives (5.9)

| 4/2025

|

Sudden Unexplained Death in Epilepsy (5.12) - removal

| 4/2025

|

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA022115 · Glaxosmithkline LLC
First approved
May 29, 2009 (17 years ago)
Latest approved change
October 10, 2025
Approved label
PDF, Oct 14, 2025
Generic makers
27 approved generic applications on the market
Last patent listed
January 7, 2029

Lamotrigine questions

How much does lamotrigine cost without insurance?

Pharmacies pay about $1.45 for 30 tablets of lamotrigine 100 mg tablet ($0.0483 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $12.17. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of lamotrigine?

Lamotrigine is sold as Lamictal, Subvenite. The generic has the same active ingredient and usually costs far less.

Is lamotrigine in shortage?

Yes. 6 products are listed as in shortage or being discontinued (being discontinued). See which ones.

Has lamotrigine been recalled?

13 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the lamotrigine label last change?

The official label was last updated on June 25, 2026 (version 25). See what changed.

Talk about lamotrigine

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.